Annual Accounts Receivable
$6.97B$560.59M-7.45%
Summary
- Current Value
- As of today, GSK annual accounts receivable is $6.97B, down -7.45% on
- Historical Performance
- GSK annual accounts receivable is down -17.65% over the past 3 years, and down -4.15% over the past 5 years
- All-Time High Comparison
- GSK annual accounts receivable is currently -24.84% below its historical high of $9.27B set on
- 3-Year Low Comparison
- GSK annual accounts receivable is +6.23% above its 3-year low of $6.56B reached on an earlier date
- Sector Comparison
- GSK annual accounts receivable is higher than 97.39% of companies in Healthcare sector
Annual Accounts Receivable Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Accounts Receivable | $6.97B | -7.5% | -17.6% | -4.2% | -21.8% | |
| Quarterly Accounts Receivable | $10.69B | +7.9% | +27.5% | +5.2% | +13.3% | |
| Price | $48.22 | +44.2% | +36.3% | +24.4% | +27.6% | |
| Annual Accounts Payable | $4.34B | -8.5% | -29.4% | -21.0% | +44.7% | |
| Annual Current Assets | $21.29B | -10.4% | -15.8% | -17.6% | -25.0% | |
| Annual Revenue | $40.09B | +6.3% | +18.0% | -6.9% | -9.9% | |
| Annual Net Income | $3.77B | -42.9% | -22.0% | -43.9% | -57.6% | |
| Annual Cash & Cash Equivalents | $4.87B | -26.2% | -17.0% | -23.1% | -56.5% |
Annual Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $7.53B | -7.5% | |
| 5Y | $8.46B | -17.6% | |
| All | $9.27B | -24.8% |
Annual Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $6.56B | N/A | +6.2% |
| 5Y | $6.56B | +6.2% | |
| All | $381.10M | +1728.2% |
Annual Accounts Receivable History
FAQ
What is the current annual accounts receivable of GSK?
As of today, GSK annual accounts receivable is $6.97B
What is 1-year change in GSK annual accounts receivable?
GSK annual accounts receivable is down -7.45% year-over-year
What is 3-year change in GSK annual accounts receivable?
GSK annual accounts receivable is down -17.65% over the past 3 years
How far is GSK annual accounts receivable from its all-time high?
GSK annual accounts receivable is currently -24.84% below its historical high of $9.27B set on December 31, 2007
How does GSK annual accounts receivable rank versus sector peers?
GSK annual accounts receivable is higher than 97.39% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly Accounts Receivable
$10.69B$652.85M+6.51%
Summary
- Current Value
- As of today, GSK quarterly accounts receivable is $10.69B, up +6.51% on
- Historical Performance
- GSK quarterly accounts receivable is up +7.90% year-over-year, and up +27.49% over the past 3 years
- All-Time High Comparison
- GSK quarterly accounts receivable is currently -2.19% below its historical high of $10.92B set on
- 3-Year Low Comparison
- GSK quarterly accounts receivable is +62.93% above its 3-year low of $6.56B reached on an earlier date
- Sector Comparison
- GSK quarterly accounts receivable is higher than 98.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Accounts Receivable | $10.69B | +6.5% | +7.9% | +27.5% | +5.2% | |
| Annual Accounts Receivable | $6.97B | – | -7.5% | -17.6% | -4.2% | |
| Price | $48.22 | +9.3% | +44.2% | +36.3% | +24.4% | |
| Quarterly Accounts Payable | $21.10B | +3.9% | +9.4% | +17.3% | +7.8% | |
| Quarterly Current Assets | $24.02B | -0.8% | +3.5% | +6.3% | -6.5% | |
| Quarterly Revenue | $11.52B | +8.0% | +10.6% | +25.2% | +3.2% | |
| Quarterly Net Income | $2.89B | +31.5% | +3321.0% | +215.7% | +56.5% | |
| Quarterly Cash & Cash Equivalents | $4.45B | -10.3% | +3.3% | -44.3% | -21.1% |
Quarterly Accounts Receivable Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $10.69B | at high | |
| 3Y | $10.69B | at high | |
| 5Y | $10.69B | at high | |
| All | $10.92B | -2.2% |
Quarterly Accounts Receivable Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.97B | N/A | +53.4% |
| 3Y | $6.56B | N/A | +62.9% |
| 5Y | $6.56B | +62.9% | |
| All | $381.10M | +2703.8% |
Quarterly Accounts Receivable History
FAQ
What is the current quarterly accounts receivable of GSK?
As of today, GSK quarterly accounts receivable is $10.69B
What is GSK quarterly accounts receivable most recent change?
GSK quarterly accounts receivable was up +6.51% on September 1, 2025
What is 1-year change in GSK quarterly accounts receivable?
GSK quarterly accounts receivable is up +7.90% year-over-year
How far is GSK quarterly accounts receivable from its all-time high?
GSK quarterly accounts receivable is currently -2.19% below its historical high of $10.92B set on December 31, 2007
How does GSK quarterly accounts receivable rank versus sector peers?
GSK quarterly accounts receivable is higher than 98.54% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk